Healthcare of Ontario Pension Plan (HOOPP) Trust Fund’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,202,100
Closed -$48.4M 1460
2026
Q1
$48.4M Buy
+1,202,100
New +$25.9M 0.08% 204
2025
Q3
Sell
-56,000
Closed -$969K 1178
2025
Q2
$969K Buy
+56,000
New +$1.04M ﹤0.01% 816
2022
Q3
Sell
-20,300
Closed -$918K 1482
2022
Q2
$918K Buy
+20,300
New +$926K ﹤0.01% 980

Other funds holding APLS

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's APLS Position: Q2 2026 in Review

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 1,202,100 shares — an estimated $48.4M sold.

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in APLS in Q2 2022 and held it in 3 quarters. The position peaked at $48.4M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold 1,202,100 Apellis Pharmaceuticals shares in Q2 2026, an estimated $48.4M.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in Apellis Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's Apellis Pharmaceuticals position peaked at $48.4M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's 13F filing for Q2 2026, filed 13 Aug 2026.